Network of collaborations for innovation: the case of biotechnology

The ‘life science’ revolution related to the development of biotechnology affects many different markets. In the pharmaceutical business new drugs are continuously developed, tested, and submitted to governmental institutions for the required approval. In the agricultural business the so-called ‘green revolution’ is well under way with many new products designed in order to appeal to farmers or to consumers. The increasing pace of introduction of new biotech products—particularly drugs and agrochemical (Ag) foods—leads firms to look for collaborations in the different phases of the introduction process. Basing on an empirical study conducted on a sample of 27 organisations involved in the process of introduction of biotech products, the paper aims at comparing and contrasting the nature and the processes involved in inter-institutional collaborations occurring at various stages of new product development and commercialisation of new biotech products (particularly drugs and Ag foods).